Anti-Counterfeiting and Anti-Diversion Strategies


Join SMi as this Masterclass will provide an intensive look at methods to combat counterfeiting and diversion, focusing on three key pillars: physical, digital and process security.

Overall world revenue for pharmaceutical anti-counterfeiting technologies will reach $1.11bn in 2014. Rising concerns about counterfeit drugs worldwide will stimulate demand for drug security, authentication and verification solutions. According to a research company, a market intelligence company specializing in global connectivity and emerging technology, drug counterfeiting is a worldwide criminal enterprise, costing drug manufacturers $30 billion a year in lost revenue and brand deterioration.

Why should you attend?

•Understand the current criminal threats to your supply chain
•Analyse and debate the best strategies to keep products secure and patients safe
•Get the latest information on how forthcoming legal requirements in EU, US and elsewhere will affect your organisation
•Learn how to turn must-do compliance into added-value opportunity
•Network with and learn from other senior industry representatives

This Masterclass will be hosted by: Mark Davison, Blue Sphere Health

For full conference programme please visit: www.smi-online.co.uk/2014anti-counterfeiting1.asp

For more information please contact: Daniel Lee on +44 (0) 207 827 6078 or email at dlee@smi-online.co.uk

Visitors

Who Should Attend?

Pharma Companies:
Directors, Associate Directors, Managing Directors

Management Consultancies:
Managing Directors, Partners, Directors, CEO

Healthcare Providers:
Pharmacist, Business Development

Exhibitors

Who Should Attend?

Pharma Companies:
Directors, Associate Directors, Managing Directors

Management Consultancies:
Managing Directors, Partners, Directors, CEO

Healthcare Providers:
Pharmacist, Business Development

Go to event website